Monitoring Anticoagulation During Percutaneous Coronary Interventions.

Monitoring of the activated clotting time in the interventional catheterization suite is essential to minimize the risk of acute thrombotic occlusion, as well as to minimize the risk of bleeding-related complications postprocedure. Based on the technique used, a Hemochron ACT of >400 seconds or a HemoTec ACT of >300 seconds is associated with a low risk of acute thrombotic occlusion. Avoiding an ACT of >500 seconds should minimize the risk of procedure-related bleeding complications.